2 recruiting, 1 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Atorvastatin 40mg: new trials by email Literature Review of Atorvastatin 40mg trials Research Report on Atorvastatin 40mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke Atorvastatin 40mg, Rosuvastatin 20mg - Ischemic Stroke | Phase 3 | Recruiting | Kafrelsheikh University | 600 | 2024-04-10 | 2026-04-23 |
| Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion Atorvastatin 40mg, Placebo oral tablet - Tuberculosis, Pulmonary | Phase 2 / Phase 3 | Recruiting | University of Cape Town | 220 | 2020-07-14 | 2024-08-23 |
| A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia Fimasartan 120mg, Atorvastatin 40mg, Placebo for Fimasartan 120mg - Essential Hypertension, Dyslipidemia | Phase 3 | Completed | Boryung Pharmaceutical Co., Ltd | 133 | 2018-01-15 | 2019-11-05 |
Dyslipidemias (1) · Essential Hypertension (1) · Inflammation (1) · Ischemic Stroke (1) · Pulmonary Disease, Chronic Obstructive (1) · Stroke (1) · Tuberculosis (1) · Tuberculosis, Pulmonary (1)
Boryung Pharmaceutical Co., Ltd (1) · Kafrelsheikh University (1) · University of Cape Town (1)
Egypt (1) · South Africa (1) · South Korea (1)
Friedrich Thienemann, MD (1) · Reto Guler, PhD (1)